Dr. Ali Reza Emami Ardakani

Iran . Tehran

education:

Medical School Graduation, Shahid Beheshti University

Iranian board of nuclear medicine, Tehran university

Academic degrees:

Assistant Professor of Nulcear Medicine, Tehran University of Medical Science

Associate Professor of Nuclear Medicine Tehran University of Medical Sciences since

Publication:

Eftekhari, M., Fard-Esfahani, A., Haghighatafshar, M., Keivan, A., Beiki, D., Agahosseini, F., Emami-Ardekani, A., Saghari, M. : Bone scan with incidental visualization of the entire colon, Iranian Journal of Nuclear Medicine. 2010; 18(2), pp. 56-59.

Fard-Esfahani, A., Beiki, D., Fallahi, B., Mohajeri-Tehrani, M.R., Gharaie, M.R., Rouhipour, N., Dehghanian, M., Saghari, M., Emami-Ardekani, A., Eftekhari, , M. : Evaluation of 99mTc-ubiquicidin 29-41 scintigraphy in differentiation of bacterial infection from sterile inflammation in diabetic foot, Iranian Journal of Nuclear Medicine. 2010; 18(2), pp. 20-28.

Fard-Esfahani, P., Beiki, D., Fallahi, B., Fard-Esfahani, A., Emami-Ardekani, A., Ansari, M., Eftekhari, M. : Radioiodine therapy for hyperthyroidism, Iranian Journal of Nuclear Medicine. 2011; 19(2), pp. 1-12.

Kalantari F., Rajabi H., Saghari M., Emami Ardekani A.: Assessment of the effect of 3D resolution recovery during SPECT image reconstruction on quantification of small liver tumors: A simulation study, IEEE Nuclear Science Symposium Conference Record.2011; Pages 2891-2894.

Kalantari, F., Rajabi, H., Saghari, M., Ardekani, A.E.: A model based, anatomy dependent method for ultra-fast creation of primary SPECT projections, Iranian Journal of Nuclear Medicine. 2011 ; Volume 19, Issue 1, Pages 21 – 29.

Fard-Esfahani, A., Farzanefar, S., Fallahi, B., Beiki, D., Saghari, M., Emami-Ardekani, A., Majdi, M., Eftekhari, M. : Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer , Nuclear Medicine Communications . 2012 ; 33(10), pp. 1077-1080.

Fard-Esfahani, A., Fallahi, B., Mirpour, S., Gholamrezanezhad, A., Abdi, E., Karimi, M., Beiki, D., Emami-Ardekani, A., Akhzari, F., Ansari, M., Eftekhari, M. : Evaluation of myocardial perfusion and function after kidney transplantation by gated SPECT myocardial perfusion scintigraphy, Iranian Journal of Nuclear Medicine. 2012 ; 20(2), pp. 20-24.

Kalantari, F., Rajabi, H., Ay, M.R., Razavi-Ratki, S.K., Fard-Esfahani, A., Beiki, D., Eftekhari, M., Fallahi, B., Sadeghian, L., Emami-Ardekani, A. : The influence of resolution recovery by using collimator detector response during 3D OSEM image reconstruction on 99mTc-ECD brain SPET images, Hellenic Journal of Nuclear Medicine . 2012 ; 15(2), pp. 92-97+165.

Emami-Ardekani, A., Fallahi, B., Amini, M., Fard-Esfahani, A., Beiki, D., Farzanefar, S., Abbasi, M., Sadeghian, L., Eftekhari, M., Saghari, M. : Accuracy of modification of diet for renal disease and Cockcroft-Gault equations as compared to the radioisotope double sample method: A study in patients with acute renal failure, Iranian Journal of Nuclear Medicine . 2014 ; 22(1), pp. 23-28.

Fallahi, B., Fard-Esfahani, A., Hassanzadeh-Rad, A., Emami-Ardekani, A., Beiki, D., Eftekhari, M. : Comparison of transient ischemic dilation ratios in SPECT and SPECT-CT myocardial perfusion imaging in the low pre-test probability group , Iranian Journal of Nuclear Medicine. 2014 ; 22(2), pp. 51-56.

Fard-Esfahani, A., Emami-Ardekani, A., Fallahi, B., Fard-Esfahani, P., Beiki, D., Hassanzadeh-Rad, A., Eftekhari, M. : Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma , Nuclear Medicine Communications . 2014 ;  35(8), pp. 808-817.

Emami-Ardekani, A., Esteghamati, A., Farzanefar, S., Abousaidi, M., Abbasi, M., Abdollahi, S., Fallahi, B., Beiki, D., Fard-Esfahani, A., Nakhjavani, M., Eftekhari, M. : Folate therapy improves the stress-to-rest mean LV volume ratio in myocardial perfusion imaging in patients with diabetes , Annals of Nuclear Medicine . 2015 ; 29(8), pp. 740-744.

Beiki, D., Karami, F., Fallahi, B., Kaviani, A., Harirchi, I., Omranipour, R., Erfani, M., Farzanefar, S., Fard-Esfahani, A., Emami-Ardekani, A., Saghari, M., Eftekhari, M. : Evaluation of a new 99mTc-Bombesin analog in differentiation of malignant from benign breast tumors , Iranian Journal of Nuclear Medicine. 2015 ; 23(2), pp. 103-107.

Chavoshi, M., Fard-Esfahani, A., Fallahi, B., Emami-Ardekani, A., Beiki, D., Hassanzadeh-Rad, A., Eftekhari, M. : Assessment of prognostic value of semiquantitative parameters on gated single photon emission computed tomography myocardial perfusion scintigraphy in a large middle eastern population , Indian Journal of Nuclear Medicine .2015 ; 30(3), pp. 233-238.

Beiki, D., Tajik, M., Haddad, P., Fallahi, B., Arefpour, A.M., Mirzaei, H., Fard-Esfahani, A., Emami-Ardekani, A., Eftekhari, M. : Effectiveness and complications of 188Re-HEDP in palliative treatment of diffuse skeletal metastases , Iranian Journal of Nuclear Medicine . 2015 ; 23(1), pp. 44-4.

Salehi, Y., Fard-Esfahani, A., Fallahi, B., Aghahosseini, F., Beiki, D., Emami-Ardekan, A., Fard-Esfahani, P., Ansari, M., Eftekhari, M. : The myocardial perfusion scintigraphy in asymptomatic diabetic patients, Iranian Journal of Nuclear Medicine. 2015 ; 23(1), pp. 27-35.

Fard-Esfahani, A., Fallahi, B., Karimi, M., Beiki, D., Saghari, M., Emami-Ardekani, A., Fard-Esfahani, P., Ansari, M., Eftekhari, M. : Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease , Iranian Journal of Nuclear Medicine. 2015 ; 23(1), pp. 1-7.

Eftekhari M, Anbiaei R, Zamani H, Fallahi B, Beiki D, Ameri A, Emami-Ardekani A, Fard-Esfahani A, Gholamrezanezhad A, Seid Ratki KR, Roknabadi AM. : Radiation-induced myocardial perfusion abnormalities in breast cancer patients following external beam radiation therapy, Asia Ocean J Nucl Med Biol. 2015 Winter;3(1):3-9.

Katal, S., Hassanzadeh-Rad, A., Eftekhari, M., Fard-Esfahani, A., Beiki, D., Fallahi, B., Emami-Ardekani, A., Abbasi, M. : Two-day stress-rest lower limbs perfusion scan in patients referred for myocardial perfusion imaging , Iranian Journal of Nuclear Medicine . 2016 ; 24(2), pp. 120-128.

Fard-Esfahani, A., Marzban, M., Emami-Ardekani, A., Hassanzadeh-Rad, A., Fallahi, B., Beiki, D., Geramifar, P., Eftekhari, M. : Spinal cord metastasis from testicular seminoma detected by F-18 FDG PET/CT study prior to neurological symptoms: An unusual presentation , Iranian Journal of Nuclear Medicine. 2016 ; 24(2), pp. 146-148.

Ratki, S.K.R., Fallahi, B., Namiranian, N., Emami-Ardekani, A., Saghari, M., Mirabzadeh, A., Fard-Esfahani, A., Beiki, D., Eftekhari, M., Pooyafard, F. : Factors affecting the quality of life of well-differentiated thyroid carcinoma patients: A cross-sectional study on 435 Iranian patients , Iranian Journal of Nuclear Medicine. 2016 ; 24(2), pp. 92-97.

Fallahi, B., Esmaeili, A., Beiki, D., Oveisgharan, S., Noorollahi-Moghaddam, H., Erfani, M., Tafakhori, A., Rohani, M., Fard-Esfahani, A., Emami-Ardekani, A., Geramifar, P., Eftekhari, M. : Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders, Annals of Nuclear Medicine. 2016 ; 30(2), pp. 153-162.

Fallahi, B., Moasses-Ghafari, B., Fard-Esfahani, A., Geramifar, P., Beiki, D., Emami-Ardekani, A., Eftekhari, M.; Factors influencing the pattern and intensity of myocardial 18F-FDG uptake in oncologic PET-CT imaging , Iranian Journal of Nuclear Medicine. 2017 ; 25, pp. 52-61.

Farzanefar, S., Esteghamati, A., Meshkinghalam, E., Naseri, M., Baseri, F., Abbasi, M., Emami-Ardekani, A., Fard-Esfahani, A., Fallahi, B., Eftekhari, M. : Muscle perfusion scan for prediction of anticipated diabetic foot ulceration , Iranian Journal of Nuclear Medicine, 2017;  25, pp. 35-39.

Eftekhari, M., Kalantari, F., Emami-Ardekani, A., Amini, H., Fard-Esfahani, A., Fallahi, B., Beiki, D., Farzanefar, S., Kalantari, E., Hasanzadeh-Rad, A., Abbasi, M. : Radiation induced myocardial perfusion abnormalities in patients with left breast cancer: A prospective study with short and long term follow up , Iranian Journal of Nuclear Medicine. 2017 ; 25, pp. 21-25.

Fallahi, B., Beiki, D., Salehi, Y., Emami-Ardekani, A., Fard-Esfahani, A., Aghahosseini, F., Haghighatafshar, M., Eftekhari, M. : Reverse perfusion pattern in myocardial perfusion imaging using technetium-99m-sestamibi in patients with intermediate risk for coronary artery disease in relation to the time of acquisition and intensity of visceral uptake as artifactual causes, Nuclear Medicine Communications. 2017 ; 38(1), pp. 15-20.

Fallahi, B., Fard-Esfahani, A., Emami-Ardekani, A., Sahari, S., Beiki, D., Hassanzadeh-Rad, A., Abedi, S.M., Geramifar, P., Eftekhari, M.: How to manage patients with undetectable thyroglobulin but thyroid residue after radioiodine ablative therapy in differentiated thyroid carcinoma, retreatment or observation? , Iranian Journal of Nuclear Medicine. 2017 : 25(1), pp. 51-59.

Fallahi, B., Beiki, D., Salehi, Y., Emami-Ardekani, A., Fard-Esfahani, A., Aghahosseini, F., Eftekhari, M. : Benefits of combined pharmacologic and submaximal exercise stress on Sub-diaphragmatic activity in myocardial perfusion scintigraphy, Iranian Journal of Nuclear Medicine. 2018 ; 26(2), pp. 105-111.

Emami-Ardekani, A., Mirzabeigi, A., Fard-Esfahani, A., Fallahi, B., Beiki, D., Hassanzadeh-Rad, A., Geramifar, P., Eftekhari, M.: Comparing diagnostic performance of 131I-metaiodobenzylguanidine (131I-MIBG) and 99mTc-hydrazinonicotinyl-Tyr3-Octreotide (99mTc-HYNIC-TOC) in diagnosis and localization of pheochromocytoma and neuroblastoma, Iranian Journal of Nuclear Medicine. 2018 ; 26(2), pp. 68-75.

Emami-Ardekani, A., Harsini, S., Eftekhari, M. : Vasculitis of ascending aorta detected on FDG PET/CT in a patient with fever of unknown origin, Heart Asia. 2018 ; 10(2),e011064.

Fallahi B, Manafi-Farid R, Eftekhari M, Fard-Esfahani A, Emami-Ardekani A, Geramifar P, Akhlaghi M, Hashemi Taheri AP, Beiki D. : Diagnostic fficiency of 68 Ga-DOTATATE PET/CT as ompared to 99m Tc-Octreotide SPECT/CT andonventional orphologic odalities in euroendocrine umors, Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):129-140.

Emami-Ardekani, A., Amini, H., Harsini, S., Fard-Esfahani, A., Eftekhari, M. : Unusual false-positive results of whole-body 131I scintigraphy: Four different case scenarios, Iranian Journal of Nuclear Medicine. 2019 ; 27(2), pp. 149-153.

Emami-Ardekani, A., Harsini, S., Fard-Esfahani, A., Baseri, F., Eftekhari, M. : 18F-FDG PET/CT findings in a possible MELAS syndrome: A case study , Iranian Journal of Nuclear Medicine. : 2019 ; 27(1), pp. 57-59.

Fard-Esfahani, A., Beiki, D., Harsini, S., Emami-Ardekani, A., Fallahi, B., Eftekhari, M. : Absent radiotracer uptake in thyroid gland in parathyroid scintigraphy with 99mTc-MIBI: A case report, Iranian Journal of Nuclear Medicine. 2019 ; 27(2), pp. 142-145.

Shahrokhi P, Emami-Ardekani A, Harsini S, Eftekhari M, Fard-Esfahani A, Fallahi B, Karamzade Ziarati N, Akhlaghi M, Farzanefar S, Hashemi Taheri AP, Beiki D : 68 Ga-DOTATATE PET/CT Compared with 131 I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors, Asia Ocean J Nucl Med Biol. 2020 Winter;8(1):8-17.

Emami-Ardekani, A., Harsini, S., Fard-Esfahani, A., Eftekhari, M. : Multiple myeloma in a patient with suspected hyperparathyroidism, Iranian Journal of Nuclear Medicine. 2020 ; 28(1), pp. 43-47

Fard-Esfahani, A., Valipouri, M.R., Harsini, S., Beiki, D., Emami-Ardekani, A., Fallahi, B., Eftekhari, M. : Predictors of success of the ablative/therapeutic radioiodine (131I) in differentiated thyroid cancer, Iranian Journal of Nuclear Medicine. 2020 ; 28(1), pp. 14-20

Fard-Esfahani A.a,Saidi B.aSend mail to Saidi B.,Emami-Ardekani A.a,Fallahi B.a,Beiki D.a,Mirshahvalad S.A.a,Eftekhari M.a: Adrenal lesions: Common findings and pitfalls on 18F-FDG PET/CT. Iranian Journal of Nuclear Medicine. July 2021; Volume 29, Issue 2, Pages 97 – 103

Harsini S.a, b,Fallahi B.a,Ziarati N.K.a,Razi A.c,Amini E.d,Emami-Ardekani A.a,Fard-Esfahani A.a,Parizi M.K.e,Farzanehfar S.f: A prospective study on [68ga]-PSMA PET/CT imaging in newly diagnosed intermediate-and high-risk prostate cancer, Asia Oceania Journal of Nuclear Medicine and Biology, 2021, Volume 9, Issue 2, Pages 101 – 110.

Fard-Esfahani A.a,Saidi B.aSend mail to Saidi B.,Seyedinia S.a,Emami-Ardekani A.a,Eftekhari M.a: Potential role of 18F-FDG PET/CT in a case of progressive rosai dorfman disease, Asia Oceania Journal of Nuclear Medicine and Biology,2021; Volume 9, Issue 1, Pages 62 – 66

Babak Fallahi, Niloufar Khademi, Najme Karamzade-Ziarati, Armaghan Fard-Esfahani, Alireza Emami-Ardekani, Saeed Farzanefar, Mohammad Eftekhari, Davood Beiki : 99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer, Clin Nucl Med,2021; 1;46(2):e68-e74

Graduated from Tehran University of Medical Sciences with honors

Top student Award in national Board of Nuclear Medicine